Apyx Medical (APYX) Cash & Current Investments (2010 - 2026)
Apyx Medical's (APYX) quarterly Cash & Current Investments came in at $31.1 million in Q1 2026, little changed YoY from $31.0 million in Q1 2025, and down 1.9% on a QoQ basis from $31.7 million in Q4 2025.
Apyx Medical (APYX) Cash & Current Investments (2010 - 2026) Analysis & Trends
Apyx Medical (APYX) has 17 years of Cash & Current Investments data on file, last reported at $31.1 million in Q1 2026.
- Quarterly Cash & Current Investments changed 0.41% year-over-year to $31.1 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $31.1 million (changed 0.41% YoY) and the FY2025 annual result came in at $31.7 million, changed 0.0% from the prior year.
- Cash & Current Investments eased to $31.1 million in Q1 2026, from $31.7 million in the prior quarter.
- In the past five years, Cash & Current Investments ranged from a high of $43.7 million in Q4 2023 to a low of $10.2 million in Q4 2022.
- A 5-year average of $26.5 million and a median of $28.0 million in 2024 frame the typical range for Cash & Current Investments.
- Annual changes were most pronounced in 2022 — Cash & Current Investments plunged 66.98% — and 2023, when it soared 328.3%.
- Tracing APYX's Cash & Current Investments over 5 years: stood at $10.2 million in 2022, then soared by 328.3% to $43.7 million in 2023, then decreased by 27.29% to $31.7 million in 2024, then decreased by 0.0% to $31.7 million in 2025, then decreased by 1.9% to $31.1 million in 2026.
- The last three Cash & Current Investments figures came in at $31.1 million (Q1 2026), $31.7 million (Q4 2025), and $25.1 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Current Investments (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.70 Bn | 193.10 Bn | 7.27 Bn | 5.60 Bn |
| 2 | Stryker | 125.85 Bn | 122.37 Bn | 4.50 Bn | 3.48 Bn |
| 3 | Medtronic | 118.44 Bn | 109.22 Bn | 6.41 Bn | 9.22 Bn |
| 4 | Boston Scientific | 72.64 Bn | 72.10 Bn | 3.85 Bn | 539.00 Mn |
| 5 | Edwards Lifesciences | 51.94 Bn | 47.69 Bn | 1.35 Bn | 4.25 Bn |
| 6 | Dexcom | 34.48 Bn | 32.53 Bn | 830.00 Mn | 1.95 Bn |
| 7 | GE HealthCare Technologies | 33.60 Bn | 31.49 Bn | 2.18 Bn | 2.11 Bn |
| 8 | Koninklijke Philips | 26.30 Bn | 22.98 Bn | 4.55 Bn | 3.32 Bn |
| 9 | Steris | 23.00 Bn | 22.52 Bn | 684.20 Mn | 482.30 Mn |
| 10 | Apyx Medical | 134.62 Mn | 107.00 Mn | 8.87 Mn | 27.62 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 27.62 Mn |
| Mar 31, 2026 | 31.14 Mn |
| Dec 31, 2025 | 31.74 Mn |
| Sep 30, 2025 | 25.14 Mn |
| Jun 30, 2025 | 29.30 Mn |
| Mar 31, 2025 | 31.01 Mn |
| Dec 31, 2024 | 31.74 Mn |
| Sep 30, 2024 | 28.01 Mn |
| Jun 30, 2024 | 32.68 Mn |
| Mar 31, 2024 | 37.28 Mn |
| Dec 31, 2023 | 43.65 Mn |
| Sep 30, 2023 | 22.10 Mn |
| Jun 30, 2023 | 18.50 Mn |
| Mar 31, 2023 | 16.26 Mn |
| Dec 31, 2022 | 10.19 Mn |
| Sep 30, 2022 | 14.83 Mn |
| Jun 30, 2022 | 20.06 Mn |
| Mar 31, 2022 | 26.23 Mn |
| Dec 31, 2021 | 30.87 Mn |
| Sep 30, 2021 | 30.90 Mn |